Editorial: Advances in ovarian cancer disease control

"Overall, when one considers the relative mortality to incidence annually, ovarian cancer is the second most lethal among women in the United States. It is estimated that in 2011, there will have been 21,990 new cases diagnosed and 15,460 ovarian cancer deaths [1]. Epithelial ovarian cancers and related malignancies, most predominantly high grade serous tumors, contribute most to this public health care burden [2], and thus will be the focus here. While it is beyond the scope to recognize all recent contributions, the purpose of this editorial is to report on several key advances in disease classification, public health, treatment, detection and prevention and to place these advances in context of pre-existing knowledge......"